Introduction
The root bark of Morus alba L., called "Sang-Baek-Pi" in Korea, has been used in traditional medicines for the treatment of lung-heat, cough, asthma, hematemesis, dropsy and hypertension. 1 Previous phytochemical investigations resulted in the isolation of polyphenolic constituents including prenylated flavonoids, benzofurans and Diels-Alder type adducts with various biological activities such as cytotoxicity, antioxidant, cancer cell invasion, migration and hepatoprotection. [2] [3] [4] In addition, the prenylated flavonoids, main constituents of this plant, have also been shown to exhibit various anti-inflammatory activities. 5, 6 However, the pharmacological evaluation on the minor constituents of the root bark of M. alba has not been performed in detail, because of its difficulty for the isolation and the presence of trace amount. In the present study, by means of repeated column chromatography MHz ( 1 H) and 125 MHz ( 13 C), respectively, with chemical shifts given in ppm (δ) . TLC was carried out on precoated Kieselgel 60 F 254 (art. 5715, Merck) and RP-18 F 254 s (art. 15389, Merck) plates. Column chromatography was performed on silica gel 60 (40 -63 and 63 -200 μm, Merck), MCI gel CHP20P (75 -150 μm, Mitsubishi Chemical Co.), and Sephadex LH-20 (25 -100 μm, Sigma). Low pressure liquid chromatography was carried out over a Merck Lichroprep Lobar®-A RP-18 (240 × 10 mm) column with a FMI QSY-0 pump (ISCO).
Plant materials − The root bark of Morus alba L. were collected in Geongju, Geongbuk province, Korea, and authenticated by Prof. J. H. Lee (Dongguk University, Gyoungju, Korea). The voucher specimen (CSU-1048-17) was deposited in the Herbarium of the College of Pharmacy, Chosun University.
Extraction and isolation of compounds − The dried root barks of M. alba (12 kg) were extracted three times with MeOH under reflux and 1511.6 g of residue were produced. The MeOH extract was suspended in water and then partitioned sequentially with equal volumes of dichloromethane (CH 2 Cl 2 ), ethyl acetate (EtOAc), and nbutanol (n-BuOH). Each fractions were evaporated in vaccuo to yield the residues of CH 2 Cl 2 (318.2 g), EtOAc (192.2 g), n-BuOH (182.4 g), and water (534.3 g) extract. The CH 2 Cl 2 fraction (25.0 g) was chromatographed over a silica gel column using a gradient solvent system of nhexane-EtOAc (10:1→1:5, MeOH) to give six subfractions (D1-D6). Subfraction D3 (3.1 g) was subjected to silica gel column chromatography (CC) eluting with a gradient solvent system of n-hex-EtOAc (5:1→1:1, MeOH) to yield eight subfractions (D31-D38). Subfraction D33 (0.88 g) was purified by repeated LiChroprep RP 18 CC (MeOH-H 2 O, 5:1) and prep-HPLC (75% aq. MeOH) to give 5 (56.20 mg) and 6 (24.10 mg), respectively. Subfraction D34 (0.41 g) was purified by repeated LiChroprep RP 18 CC (MeOH-H 2 O, 5:1) and prep-HPLC (78% aq. MeOH) to give 7 (14.3 mg). The EtOAc fraction (12.1 g) was chromatographed over a silica gel column using a gradient solvent system of n-hexane-EtOAc (2:1→1:8, EtOAc, MeOH) to give five subfractions (E1-E5). Subfraction E1 (0.6 g) was subjected to silica gel CC eluting with a gradient solvent system of n-hex-EtOAc (10:1→ 4:1, MeOH) to yield seven subfractions (E11-E17). Subfraction E15 (0.39 g) was purified by MCI gel CC (MeOH-H 2 O, 3:1) to give 3 (16.29 mg) and 4 (122.40 mg), respectively. Subfraction E17 (0.13 g) was purified by prep-HPLC (80% aq. MeOH) to yield 10 (4.50 mg) and 11 (11.80 mg), respectively. Subfraction E2 (3.88 g) was subjected to MCI gel column chromatography (CC) eluting with a gradient solvent system of MeOH-H 2 O (1:1 →3:1) to yield sixteen subfractions (E21-E216). Subfraction E23 (0.033 g) was purified by LiChroprep RP 18 CC (MeOH-H 2 O, 1:1) to yield 8 (5.22 mg). Subfraction E24 (0.212 g) was subjected to silica gel CC ( Bioassay of IL-6 − IL-6 bioassay was carried out using a slight modification of an established method. 7, 8 Briefly, 500 μL of the MG-63 cells (3 × 10 4 cells/mL) in DMEM containing 10% FBS were dispensed into a 24-well plate, the culture was incubated for 24 h at 37 o C. Then, 5 μL of TNF-α (10 ng/mL), 5 μL of BAY 11-7085 (10 ng/mL), and 5 μL of the DMSO with or without the compounds (100 μg/mL) were added. After incubation at 37 o C with 5% CO 2 for 24 h, the medium was stored at -20 o C until measurement. The IL-6 content of the medium was measured in an ELISA procedure. 96-well plates were coated with 100 μL of purified rat anti-human IL-6 monoclonal antibody in 0.1 M NaHCO 3 (pH 9.6) by overnight incubation at 4 o C. The wells were blocked with 200 μL of 3% BSA in PBS for 2 h at room temperature (RT) and then incubated with 100 μL of specific antibody for 2 h at RT. 100 μL of HRP conjugated rabbit anti-goat IgG (1:1000 dilution) was added to each well and incubated for 2 h at RT. 100 mL of TMB (3,3',5,5'tetramethyl-benzidine) substrate solution was added and incubated for 10 min at RT. The color reaction was stopped with 50 μL of 0.4 N HCl and the optical density was read at 450 nm using a Microplate Reader (Molecular Devices Co., Ltd., U.S.A.).
Result and Discussion
Repeated column chromatography of the CH 2 Cl 2 and EtOAc soluble fractions of the root bark of M. alba yielded eleven compounds (1 -11) (Fig. 1 ). The structures of eleven known compounds were identified as kuwanon G (1), kuwanon E (2), kuwanon T (3), morusin (4), sanggenon A (5), sanggenon M (6), sanggenol A (7), moracin R (8), mulberofuran G (9), mulberofuran A (10) and mulberofuran B (11) , by comparing their spectroscopic data with those reported in the literature. [3] [4] [9] [10] [11] [12] [13] [14] [15] Among 11 isolates, compounds 8 -10 were minor compounds. IL-6 is a cytokine, originally identified as a T-cell derived factor that regulates B-cell growth and differentiation. 16 Human IL-6 is an important component of the inflammatory cascade. Dysregulation of IL-6 production has been implicated in a variety of inflammatory/ autoimmune disease states, including rheumatoid arthritis, cardiac myxoma, Castleman's disease, and mesangial proliferative glomerulonephritis. 17 The proinflammatory cytokines IL-1 and TNF-α markedly stimulate the production IL-6. 18 The inhibitory activity of the isolated compounds (1 -11) against IL-6 production in TNF-α stimulated MG-63 cells was examined. In our results, all isolated compounds (1 -11) showed excellent inhibitory activity against IL-6 production in TNF-α stimulated MG-63 cells ( Table 1 ). In the previous other studies, it has already reported that M. alba has an anti-inflammatory effect. In addition, other previous studies also reported that some components from M. alba have regulated the proinflammatory cytokines. 6, 19, 20 Especially, among the 11 compounds isolated from M. alba in this study, some compounds already have been reported to regulate inflammatory factors in this previous study.
First, in the previous studies, kuwanon G (1) isolated from M. alba significantly decreased inflammatory cytokines in macrophages, 21 and inhibited the IgE and Th2 cytokines including IL-4, IL-5, and IL-13 produc-tions in a mouse model of asthma. 22 In addition, it was already reported that kuwanon E (2), kuwanon T (3), and moracin R isolated from M. alba showed significant reduction of nitric oxide (NO) production in RAW264.7 cells. 6 Morusin is a well-known to strongly inhibit the inflammatory action and it is also reported particularly effective in the regulation of cytokines. 6, 23, 24 Similar to previous other studies, our present study also demonstrated that kuwanon G (1), kuwanon E (2), kuwanon T (3), morusin (4), and moracin R (8) significantly inhibited IL-6 production in MG-63 cells (Table 1) .
However, the inhibitory effect of cytokine production Vol. 25, No. 3, 2019 273 or inflammatory response by sanggenon A (5), sanggenon M (6), sanggenol A (7), mulberofuran G (9), mulberofuran A (10) and mulberofuran B (11) has not been reported yet. Sanggenon C and O have been reported to inhibit the inflammatory response through inhibition of NF-κB activation, 25 and sanggenon B and sanggenon D are known to regulate cyclooxygenases and lipoxygenases. 23 However sanggenon A (5) and sanggenon M (6) were not known about the anti-inflammatory effects. In addition, sanggenol A (7) was reported to protective effects on glutamate-induced neuronal cell death, 26 but the regulating effects of anti-inflammatory and cytokine were not noted. Furthermore, among mulberofuran type compounds, only mulberofuran K has been reported to have anti-inflammatory activity, 27 but mulberofuran G (9), mulberofuran A (10), and mulberofuran B (11) have unknown to the regulatory action of inflammatory cytokines. In the previous studies, mulberofuran G (9) only showed antioxidative action, 28 strong antibacterial activity, 29 and anti-hepatitis B virus activity. 30 Therefore, this study is first time to report that sanggenon A (5), sanggenon M (6), sanggenol A (7), mulberofuran G (9), mulberofuran A (10) and mulberofuran B (11) isolated from M. alba showed the inhibitory activity of IL-6 production, and it suggested the possibility of anti-inflammatory regulation by these isolated compounds (1 -11) . Further research will be conducted to investigate the mechanism of anti-inflammatory activity or IL-6 inhibition by the isolated compounds (1 -11). MG-63 cells (3×10 4 cell/well) were incubated for 24 h. Cultures were incubated with or without compounds (100 µg/mL) for 30 min and then stimulated with TNF-α (10 ng/mL) for 24 h. IL-6 in the supernatant was measured by ELISA as described in Materials and Methods. Results are expressed as the mean ± S.E. from three different experiments. BAY 11-7085 was used as a positive control. *P < 0.05 or **P < 0.01 compared with TNF-α treated value.
